Mabpharm Moves to Update Constitution for Treasury Shares and Digital Governance

Mabpharm Limited ( (HK:2181) ) has provided an announcement.

Mabpharm Limited plans to amend its memorandum and articles of association to align with updated Hong Kong company law, stock exchange rules, and the expanded paperless listing regime. The proposed changes will also allow the company to hold treasury shares for potential resale or transfer, provide greater flexibility for hybrid or fully electronic general meetings, and implement related housekeeping amendments.

These amendments require shareholder approval by special resolution at the upcoming annual general meeting, where adoption of an amended and restated memorandum and articles will be put to a vote. A circular detailing the proposed changes and the AGM notice will be sent to shareholders, signaling incremental but meaningful adjustments to corporate governance and capital management practices for investors.

The most recent analyst rating on (HK:2181) stock is a Hold with a HK$0.51 price target. To see the full list of analyst forecasts on Mabpharm Limited stock, see the HK:2181 Stock Forecast page.

More about Mabpharm Limited

Mabpharm Limited is a Cayman Islands-incorporated company listed on the Hong Kong Stock Exchange under stock code 2181. The company operates within the biopharmaceutical and life sciences sector, focusing on the development and commercialization of antibody-based therapeutics for the Chinese and broader Asian healthcare markets.

Average Trading Volume: 1,579,219

Technical Sentiment Signal: Buy

Current Market Cap: HK$2.31B

See more data about 2181 stock on TipRanks’ Stock Analysis page.